| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 02/27/2026 | ±3.0% | -5.9% | under-priced |
| 11/07/2025 | ±2.4% | +3.2% | under-priced |
| 08/06/2025 | ±3.8% | -0.1% | over-priced |
| 05/06/2025 | ±3.6% | -1.2% | over-priced |
| 02/27/2025 | ±2.0% | +0.1% | over-priced |
| 11/05/2024 | ±3.4% | +1.3% | over-priced |
| 08/05/2024 | ±5.2% | -1.9% | over-priced |
| 05/10/2024 | ±2.5% | +0.1% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q4 FY2025 | — | $877M | $248M |
| Q3 FY2025 | $-0.77 | $872M | $-122M |
| Q2 FY2025 | $0.56 | $868M | $89M |
| Q1 FY2025 | $0.39 | $865M | $61M |
BXP (BXP) reports imminently, with the next report estimated for 08/26/2026. Across the last 8 reports, options priced an average ±3.3% earnings move while the stock actually moved 1.7% on average — the market has systematically over-priced BXP's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue up 2.2%. QuantLogix's live 5-factor engine currently reads BXP as a buy at 67/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →